<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04292652</url>
  </required_header>
  <id_info>
    <org_study_id>GoteborgU 01-20</org_study_id>
    <nct_id>NCT04292652</nct_id>
  </id_info>
  <brief_title>Myocardial Injury in Treatment of AAA</brief_title>
  <acronym>TREATROP</acronym>
  <official_title>Treatment With Endovascular or Open Repair for AAA - Comparison of Perioperative Myocardial Injury Detected With Holter-ECG and Troponin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Göteborg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Örebro University, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Karlstad Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Göteborg University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of elective infrarenal aneurysm surgery with open and endovascular technique,&#xD;
      respectively, for subclinical ischemic myocardial injury detectable with troponin T and/or&#xD;
      3-channel Holter ECG with ST analysis&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Traditional open surgery for abdominal aortic aneurysm (AAA) is burdened with&#xD;
      complication risk from several organ systems, and also mortality figures of 3.5 - 5.5%. Over&#xD;
      50% of early mortality can be attributed to cardiovascular complications. Myocardial&#xD;
      infarction is the dominant organ-specific cause of both early and late mortality in patients&#xD;
      operated on for AAA. Endovascular surgery (EndoVascular Aortic Repair, EVAR) was developed&#xD;
      during the 90's as an alternative method that is considered less invasive and more&#xD;
      well-tolerated from a cardiovascular perspective.&#xD;
&#xD;
      Troponin T is a very sensitive and specific marker that predicts mortality in patients with&#xD;
      acute symptoms of unstable angina and/or heart attack. Previous studies have also shown a&#xD;
      high incidence of elevated troponin levels in patients who underwent major surgical&#xD;
      procedures, especially vascular surgery, even in the absence of corresponding clinical or&#xD;
      ECG-related symptoms of cardiac muscle injury. Several studies have also demonstrated that&#xD;
      elevated troponin levels after surgery predict increased morbidity and mortality both&#xD;
      short-term and long-term.&#xD;
&#xD;
      Objective: To prospectively compare elective open and endovascular surgery of AAA with&#xD;
      respect to myocardial injury detectable with troponin T. Furthermore, to compare open and&#xD;
      endovascular AAA surgery for the total number of periods of oxygen deficiency in cardiac&#xD;
      muscle during and at early stages after surgery using a special ECG method (48-hour 3-channel&#xD;
      Holter ECG with ST analysis).&#xD;
&#xD;
      Main aim of the study: To assess whether EVAR induce less myocardial injury compared with&#xD;
      open repair for AAA.&#xD;
&#xD;
      Significance: Myocardial infarction is the predominant cause of mortality in open surgical&#xD;
      procedure for AAA. In several previous studies, troponin T rise has been associated with&#xD;
      impaired both short-term and long-term prognosis in elderly patients undergoing major&#xD;
      elective surgery. This study may provide information on whether the endovascular technique&#xD;
      provides a reduction in myocardial injury, measured as elevated troponin T or myocardial&#xD;
      ischemia with 3-channel Holter ECG. In this way, our study can provide improved decision&#xD;
      support in the choice of the most appropriate treatment method in the individual case.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2007</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ischemic myocardial injury</measure>
    <time_frame>Perioperative</time_frame>
    <description>Perioperative myocardial injury induced by the procedure</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Aortic Aneurysm, Abdominal</condition>
  <condition>Complication of Surgical Procedure</condition>
  <condition>Myocardium; Ischemic</condition>
  <arm_group>
    <arm_group_label>EVAR group</arm_group_label>
    <description>Individuals undergoing endovascular aortic repair. n=40</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OR group</arm_group_label>
    <description>Individuals undergoing open repair. n=40</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>AAA surgery</intervention_name>
    <description>EVAR is a mini invasive procedure to exclude aortic aneurysms with the intention to prevent rupture. Open repair is the traditional open surgical procedure for the same condition.</description>
    <arm_group_label>EVAR group</arm_group_label>
    <arm_group_label>OR group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive individuals accepted for either open or endovascular aortic repair in two&#xD;
        Swedish hospitals&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Accepted for AAA surgery of either one of the operative techniques&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  High anesthesiological risk&#xD;
&#xD;
          -  Preoperative cardiac condition with EF &lt; 25 or ischemic signs on preoperative&#xD;
             evaluation&#xD;
&#xD;
          -  Severe renal insufficiency with s-creatinine &gt;200&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Per Skoog, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Göteborg University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ulf Nilsson, PhD</last_name>
    <phone>+46317860000</phone>
    <email>ulf.nilsson@gu.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Gothenburg university</name>
      <address>
        <city>Gothenburg</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Per Skoog, MD, PhD</last_name>
      <phone>+467860000</phone>
      <email>per.skoog@vgregion.se</email>
    </contact>
    <investigator>
      <last_name>Per Skoog, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 28, 2020</study_first_submitted>
  <study_first_submitted_qc>February 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2020</study_first_posted>
  <last_update_submitted>February 15, 2021</last_update_submitted>
  <last_update_submitted_qc>February 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>AAA</keyword>
  <keyword>Myocardial ischemic injury</keyword>
  <keyword>Troponin</keyword>
  <keyword>Holter-ECG</keyword>
  <keyword>Vascular surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

